1045 - Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration T-lymphocyte Counts and Interferon-gamma Production

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

Presenting Author(s)

GA

Grazia Alessio, n/a

Tor Vergata Hospital
Rome, Lazio, Italy
AD

Andrea Di Lorenzo, MD

Tor Vergata University of Rome
Rome, Lazio, Italy
LC

Laura Campogiani, MD

Infectious Diseases Specialist
Tor Vergata University of Rome
Rome, Lazio, Italy
AL

Alessandra Lodi, n/a

Tor Vergata Hospital
Rome, Lazio, Italy
FB

Filippo Barreca, n/a

Tor Vergata Hospital
Rome, Lazio, Italy
AC

Angela Crea, MD

Tor Vergata University of Rome
Rome, Lazio, Italy
PV

Pietro Vitale, Infectious Diseases Specialist

Tor Vergata Hospital
Rome, Lazio, Italy
IS

Ilaria Spalliera, MD

Infectious Diseases Specialist
Tor Vergata University of Rome
Rome, Lazio, Italy
MC

Mirko Compagno, Infectious Diseases specialist

Medical doctor
Tor Vergata Hospital
Rome, Lazio, Italy
LC

Luigi Coppola, Infectious Diseases Specialist

Tor Vergata Hospital
Rome, Lazio, Italy
VM

Vincenzo Malagnino, MD, PhD

Infectious Diseases Specialist
Tor Vergata University of Rome
Rome, Lazio, Italy
ET

Elisabetta Teti, Infectious Diseases Specialist

Tor Vergata Hospital
Rome, Lazio, Italy
MA

Massimo Andreoni, MD

Full Professor in Infectious Diseases
Tor Vergata University of Rome
Rome, Lazio, Italy
LS

Loredana Sarmati, MD

Full Professor in Infectious Diseases
Tor Vergata University of Rome
Rome, Lazio, Italy
Iannetta Marco, MD, PhD

Infectious Diseases Specialist
University of Rome Tor Vergata
Rome, Lazio, Italy